Sale!

Pamorelin la 3.75

Name: Pamorelin la 3.75
Brand: DR REDDY'S LABORATORIES LTD
SKU: 041
Availability: InStock

TRIPTORELIN POWDER FOR INJECTION 3.75MG

2-8* C

MRP	:	~~MRP ₹7,036.88~~
Price	:	₹5,750.00
You Save	:	₹1,286.88 (18.29%)

1 vial(s)

SKU: 041 Category: Urology Tag: Urology Brand: DR REDDY'S LABORATORIES LTD

Pamorelin LA 3.75mg Injection contains Triptorelin as its active pharmaceutical ingredient. Triptorelin belongs to a category of medications called gonadotropin-releasing hormone (GnRH) analogs, which are primarily utilized in reproductive and hormonal therapies. These medications are designed to influence the body’s hormonal regulation processes by acting on the pituitary gland to suppress the production of certain sex hormones.

Pamorelin is widely used in the treatment of hormone-sensitive conditions, where controlling hormone levels is essential to managing the disease. Some of the most common indications for this medication include prostate cancer in men, hormone-responsive breast cancer in women, and endometriosis, a painful condition in which tissue similar to the lining of the uterus grows outside the uterine cavity. In the context of prostate cancer, Pamorelin helps reduce testosterone production, thereby slowing down or halting the growth of cancer cells that depend on this hormone for proliferation.

This injection should not be administered to individuals with known hypersensitivity or allergic reactions to Triptorelin or any other component of the formulation. Its use in pediatric populations, particularly in children, requires careful medical consideration, as the safety and effectiveness in this age group have not been fully established. Healthcare providers must evaluate the potential risks and benefits before prescribing it to young patients.

Moreover, the use of Pamorelin LA 3.75mg Injection should be approached with caution in individuals who have a history of cardiovascular conditions. This is because the medication has been associated with certain heart-related side effects, such as an elevated risk of myocardial infarction (heart attack) or cerebrovascular accidents (strokes). Patients with existing heart disease or those considered to be at high risk for cardiovascular events should be closely monitored during treatment to ensure safety.

Pamorelin LA 3.75mg Injection is used to treat the following:

Prostate cancer in men
Early onset puberty in children 2 years of age and older (precocious puberty)

Pamorelin LA 3.75mg Injection works by targeting the pituitary gland to suppress the secretion of two key reproductive hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones play a critical role in stimulating the production of sex hormones—testosterone in men and estrogen in women. By inhibiting the release of LH and FSH, Pamorelin effectively reduces the levels of these sex hormones in the body.

This hormonal suppression is particularly beneficial in managing hormone-dependent medical conditions. In prostate cancer, for instance, lowering testosterone levels helps to slow down or halt the progression of cancer cells that rely on this hormone for growth. Similarly, in cases of hormone-responsive breast cancer and endometriosis, reducing estrogen levels can alleviate symptoms, prevent further tissue growth, and contribute to better disease control. This mechanism makes Pamorelin an effective therapeutic option for patients with conditions that are driven or exacerbated by elevated sex hormone levels

It is essential to inform your doctor about all the medications you are currently taking or have recently used, including prescription drugs, over-the-counter medicines, nutritional supplements, vitamins, and herbal preparations. Some of these substances may interact with Pamorelin LA 3.75mg Injection, potentially diminishing its effectiveness or increasing the risk of unwanted side effects. By providing a complete list of your medications, your healthcare provider can carefully evaluate potential drug interactions and make necessary adjustments to ensure the safety and efficacy of your treatment with Pamorelin.

Pamorelin LA 3.75mg Injection is generally administered by a healthcare professional either subcutaneously (beneath the skin) or intramuscularly (into the muscle), depending on the treatment protocol and clinical judgment. The exact dosage and frequency of administration are tailored to each patient based on the specific medical condition being managed, as well as the individual’s overall response to the therapy. It is crucial to adhere strictly to the instructions provided by your healthcare provider regarding the method and timing of administration to ensure optimal treatment outcomes and minimize potential risks or complications

Store at room temperature, between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
It should not be frozen.
Keep away from children and pets.

Serious:

Swallowing or breathing trouble
Increased lymphocyte count in the blood
Swelling of lips, tongue or throat

Common:

Hot flushes
Weakness
Excessive sweating
Back pain
Impotence
Nausea
Dry mouth
Pain, bruising, redness at the injection site
High blood pressure
Weight gain
Dizziness
Headache

Breast Feeding

Consult Your Doctor

The safety of Pamorelin LA 3.75mg Injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.

Alcohol

Unsafe

The use of Pamorelin LA 3.75mg Injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.

Liver

Consult Your Doctor

Pamorelin LA 3.75mg Injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.

Lungs

Consult Your Doctor

Pamorelin LA 3.75mg Injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.

Driving

Unsafe

Common side effects of Pamorelin LA 3.75mg Injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.

Pregnancy

Consult Your Doctor

Pamorelin LA 3.75mg Injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.